Medical devices are becoming smaller, more expensive to assemble, and used more commonly with collaborative robotics. Miniaturization, the cost of assembly, and the complexity of designing tools for diagnostic and surgical robots are just some of the challenges that today’s medical device designers face. Micro 3D printing helps to alleviate some of these challenges. With PμSL technology, engineers can print small parts rapidly in biocompatible materials with 2μm resolution and +/-10μm accuracy.
Key takeaways from this webinar:
- How additive manufacturing and miniaturization are converging and what this means for the future
- Real world examples of how micro 3D printing is playing a significant role in solving challenges and steering innovation
- A little more about PµSL technology and how it’s becoming a game-changer in medical, biopharmaceutical and microfluidic applications
John Kawola is the CEO of Boston Micro Fabrication (BMF) an additive manufacturing technology company with a focus on high resolution, accuracy and precision. From 2016 to 2019, John served as President-Americas for Ultimaker, the leading open source desktop 3D printing company. From 2012 to 2016, John was the CEO of Harvest Automation. Harvest developed and deployed an autonomous mobile robotic platform that assists workers with difficult, repetitive material handling. John was VP of Sales and then CEO of Z Corporation from 1997 until 2012. Z Corporation led the way in introducing fast, easy to use and full color 3D printing into a wide range of industries. John is also currently the Chairman of Labminds, a laboratory automation technology company and a Board Director at Industrial ML, an industrial machine learning company. John received a BS in Mechanical Engineering from Cornell University, MS in Mechanical Engineering from Rensselaer and an MBA from Union College.